Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1990 Apr;65(4):416–422. doi: 10.1136/adc.65.4.416

Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.

J M Chessells 1, T C Cox 1, B Kendall 1, N P Cavanagh 1, L Jannoun 1, S Richards 1
PMCID: PMC1792187  PMID: 2346334

Abstract

Serial cranial computed tomograms were carried out in 136 children with acute lymphoblastic leukaemia who were receiving 24 Gy or 18 Gy of cranial irradiation and continuing treatment with doses of methotrexate given weekly orally or intramuscularly. The findings were correlated with treatment variables, the development of fits, and the intelligence quotient (IQ). Reversible brain shrinkage, attributed to treatment with steroids, was found on 87 of 114 initial scans (76%); 14 showed changes in white matter during treatment (10%), and calcification was found in 13 either during or after treatment (10%). Eight children (6%) had fits, and in six of the eight there were changes in white matter or calcification on the scans. Comparison of the two radiotherapy dosages showed no difference in the incidence of abnormalities seen on computed tomography, fits, or serial IQ measurements, but children receiving intramuscular methotrexate had a higher incidence of calcification and a lower mean IQ at one year than those who received the drug orally, although this difference was not apparent later. Younger children were more likely to develop changes on computed tomograms and fits, and to have low IQs on completion of treatment, with changes most apparent in those less than 2 years of age. There were highly significant correlations between abnormalities on computed tomography, fits, and IQ. These findings confirm the neurological vulnerability of younger children with acute lymphoblastic leukaemia, show an association between abnormalities on computed tomography and intellectual deficit, and suggest that methotrexate is more toxic when given intramuscularly than orally. They provide no evidence that 18 Gy of cranial irradiation is less toxic than 24 Gy, and indicate the need for alternative treatment regimens.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balis F. M., Savitch J. L., Bleyer W. A. Pharmacokinetics of oral methotrexate in children. Cancer Res. 1983 May;43(5):2342–2345. [PubMed] [Google Scholar]
  2. Bleyer W. A. Neurologic sequelae of methotrexate and ionizing radiation: a new classification. Cancer Treat Rep. 1981;65 (Suppl 1):89–98. [PubMed] [Google Scholar]
  3. Brouwers P., Riccardi R., Fedio P., Poplack D. G. Long-term neuropsychologic sequelae of childhood leukemia: correlation with CT brain scan abnormalities. J Pediatr. 1985 May;106(5):723–728. doi: 10.1016/s0022-3476(85)80343-7. [DOI] [PubMed] [Google Scholar]
  4. Ch'ien L. T., Aur R. J., Verzosa M. S., Coburn T. P., Goff J. R., Hustu H. O., Price R. A., Seifert M. J., Simone J. V. Progression of methotrexate-induced leukoencephalopathy in children with leukemia. Med Pediatr Oncol. 1981;9(2):133–141. doi: 10.1002/mpo.2950090206. [DOI] [PubMed] [Google Scholar]
  5. Chessells J. M., Leiper A. D., Tiedemann K., Hardisty R. M., Richards S. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia. Arch Dis Child. 1987 Feb;62(2):172–176. doi: 10.1136/adc.62.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cousens P., Waters B., Said J., Stevens M. Cognitive effects of cranial irradiation in leukaemia: a survey and meta-analysis. J Child Psychol Psychiatry. 1988 Nov;29(6):839–852. doi: 10.1111/j.1469-7610.1988.tb00757.x. [DOI] [PubMed] [Google Scholar]
  7. Jannoun L. Are cognitive and educational development affected by age at which prophylactic therapy is given in acute lymphoblastic leukaemia? Arch Dis Child. 1983 Dec;58(12):953–958. doi: 10.1136/adc.58.12.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jannoun L., Chessells J. M. Long-term psychological effects of childhood leukemia and its treatment. Pediatr Hematol Oncol. 1987;4(4):293–308. doi: 10.3109/08880018709141282. [DOI] [PubMed] [Google Scholar]
  9. Lewkonia R. M. Hypermobility of joints. Arch Dis Child. 1987 Jan;62(1):1–2. doi: 10.1136/adc.62.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Littman P., Coccia P., Bleyer W. A., Lukens J., Siegel S., Miller D., Sather H., Hammond D. Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL). Int J Radiat Oncol Biol Phys. 1987 Oct;13(10):1443–1449. doi: 10.1016/0360-3016(87)90308-7. [DOI] [PubMed] [Google Scholar]
  11. McIntosh S., Klatskin E. H., O'Brien R. T., Aspnes G. T., Kammerer B. L., Snead C., Kalavsky S. M., Pearson H. A. Chronic neurologic disturbance in childhood leukemia. Cancer. 1976 Feb;37(2):853–857. doi: 10.1002/1097-0142(197602)37:2<853::aid-cncr2820370234>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  12. Mulhern R. K., Wasserman A. L., Fairclough D., Ochs J. Memory function in disease-free survivors of childhood acute lymphocytic leukemia given CNS prophylaxis with or without 1,800 cGy cranial irradiation. J Clin Oncol. 1988 Feb;6(2):315–320. doi: 10.1200/JCO.1988.6.2.315. [DOI] [PubMed] [Google Scholar]
  13. Nesbit M. E., Jr, Sather H. N., Robison L. L., Ortega J., Littman P. S., D'Angio G. J., Hammond G. D. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study Group. Lancet. 1981 Feb 28;1(8218):461–466. doi: 10.1016/s0140-6736(81)91849-3. [DOI] [PubMed] [Google Scholar]
  14. Ochs J. J., Bowman W. P., Pui C. H., Abromowitch M., Mason C., Simone J. V. Seizures in childhood lymphoblastic leukaemia patients. Lancet. 1984 Dec 22;2(8417-8418):1422–1424. doi: 10.1016/s0140-6736(84)91621-0. [DOI] [PubMed] [Google Scholar]
  15. Ochs J. J., Parvey L. S., Whitaker J. N., Bowman W. P., Ch'ien L., Campbell M., Coburn T. Serial cranial computed-tomography scans in children with leukemia given two different forms of central nervous system therapy. J Clin Oncol. 1983 Dec;1(12):793–798. doi: 10.1200/JCO.1983.1.12.793. [DOI] [PubMed] [Google Scholar]
  16. Packer R. J., Zimmerman R. A., Bilaniuk L. T. Magnetic resonance imaging in the evaluation of treatment-related central nervous system damage. Cancer. 1986 Aug 1;58(3):635–640. doi: 10.1002/1097-0142(19860801)58:3<635::aid-cncr2820580307>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  17. Pearson A. D., Mills S., Amineddine H. A., Long D. R., Craft A. W., Chessells J. M. Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia. Cancer Chemother Pharmacol. 1987;20(3):243–247. doi: 10.1007/BF00570494. [DOI] [PubMed] [Google Scholar]
  18. Peylan-Ramu N., Poplack D. G., Blei C. L., Herdt J. R., Vermess M., Di Chiro G. Computer assisted tomography in methotrexate encephalopathy. J Comput Assist Tomogr. 1977 Apr;1(2):216–221. doi: 10.1097/00004728-197704000-00011. [DOI] [PubMed] [Google Scholar]
  19. Peylan-Ramu N., Poplack D. G., Pizzo P. A., Adornato B. T., Di Chiro G. Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med. 1978 Apr 13;298(15):815–818. doi: 10.1056/NEJM197804132981504. [DOI] [PubMed] [Google Scholar]
  20. Pfefferbaum-Levine B., Copeland D. R., Fletcher J. M., Ried H. L., Jaffe N., McKinnon W. R., Jr Neuropsychologic assessment of long-term survivors of childhood leukemia. Am J Pediatr Hematol Oncol. 1984 Summer;6(2):123–128. doi: 10.1097/00043426-198406020-00002. [DOI] [PubMed] [Google Scholar]
  21. Pinkerton C. R., Chessells J. M. Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome. Br J Haematol. 1984 Aug;57(4):553–561. [PubMed] [Google Scholar]
  22. Robison L. L., Nesbit M. E., Jr, Sather H. N., Meadows A. T., Ortega J. A., Hammond G. D. Factors associated with IQ scores in long-term survivors of childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol. 1984 Summer;6(2):115–121. doi: 10.1097/00043426-198406020-00001. [DOI] [PubMed] [Google Scholar]
  23. Rowland J. H., Glidewell O. J., Sibley R. F., Holland J. C., Tull R., Berman A., Brecher M. L., Harris M., Glicksman A. S., Forman E. Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia. J Clin Oncol. 1984 Dec;2(12):1327–1335. doi: 10.1200/JCO.1984.2.12.1327. [DOI] [PubMed] [Google Scholar]
  24. Rubinstein L. J., Herman M. M., Long T. F., Wilbur J. R. Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer. 1975 Feb;35(2):291–305. doi: 10.1002/1097-0142(197502)35:2<291::aid-cncr2820350202>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  25. Wheeler K., Leiper A. D., Jannoun L., Chessells J. M. Medical cost of curing childhood acute lymphoblastic leukaemia. Br Med J (Clin Res Ed) 1988 Jan 16;296(6616):162–166. doi: 10.1136/bmj.296.6616.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Williams J. M., Davis K. S. Central nervous system prophylactic treatment for childhood leukemia: neuropsychological outcome studies. Cancer Treat Rev. 1986 Jun;13(2):113–127. doi: 10.1016/0305-7372(86)90016-2. [DOI] [PubMed] [Google Scholar]
  27. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES